Literature DB >> 16482386

Effect of azoles on the secretion of a Candida albicans metallopeptidase.

Christine Imbert1, Sabrina Imbert-Bouyer, Catherine Kauffmann-Lacroix, Gyslaine Daniault, Marie-Hélène Rodier.   

Abstract

Azole antifungals act by inhibiting the activity of a lanosterol demethylase involved in the generation of the ergosterol of the cellular membrane of fungi. These drugs could also have action on other yeast components, like secreted aspartyl proteases. We demonstrate in this study that the in vitro secretion of a metallopeptidase could be modified during the growth of Candida albicans with subinhibitory concentrations of some azoles. Eight isolates of this yeast have been cultivated in presence of MIC, MIC/2 and MIC/4 of voriconazole, fluconazole and itraconazole. The presence of voriconazole and fluconazole decreased the secretion of the metallopeptidase in the culture medium, whereas itraconazole increased this secretion for three isolates. This study points to the fact that some antifungals, given in prophylaxis, could act in an unfavourable way on some potential factors of pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482386     DOI: 10.1007/s11046-005-3085-4

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

Review 1.  Prophylaxis of invasive mycoses in solid organ transplantation.

Authors:  Barbara D Alexander
Journal:  Curr Opin Infect Dis       Date:  2002-12       Impact factor: 4.915

2.  Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.

Authors:  T Wu; K Wright; S F Hurst; C J Morrison
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Effect of matrix metalloprotease inhibitors on the 95 kDa metallopeptidase of Candida albicans.

Authors:  C Imbert; C Kauffmann-Lacroix; G Daniault; J L Jacquemin; M H Rodier
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

Review 4.  Aspartyl proteinases of Candida albicans and their role in pathogenicity.

Authors:  F De Bernardis; P A Sullivan; A Cassone
Journal:  Med Mycol       Date:  2001-08       Impact factor: 4.076

5.  Plant sterol 14 alpha-demethylase affinity for azole fungicides.

Authors:  D C Lamb; M Cannieux; A G Warrilow; S Bak; R A Kahn; N J Manning; D E Kelly; S L Kelly
Journal:  Biochem Biophys Res Commun       Date:  2001-06-15       Impact factor: 3.575

6.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

7.  A Candida albicans metallopeptidase degrades constitutive proteins of extracellular matrix.

Authors:  M H Rodier; B el Moudni; C Kauffmann-Lacroix; G Daniault; J L Jacquemin
Journal:  FEMS Microbiol Lett       Date:  1999-08-15       Impact factor: 2.742

Review 8.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

9.  Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.

Authors:  Kirsty J McLean; Ker R Marshall; Alison Richmond; Iain S Hunter; Kay Fowler; Tobias Kieser; Sudagar S Gurcha; Gurydal S Besra; Andrew W Munro
Journal:  Microbiology       Date:  2002-10       Impact factor: 2.777

10.  Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro.

Authors:  Jean-Sébastien Ripeau; Francine Aumont; Pierre Belhumeur; Luis Ostrosky-Zeichner; John H Rex; Louis de Repentigny
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more
  1 in total

1.  Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.

Authors:  Cathrin Alvendal; Soumitra Mohanty; Nina Bohm-Starke; Annelie Brauner
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.